Treatment of Acetaminophen-Induced Liver Damage by the Administration of Modulators of Nitric Oxide
申请人:Goessling Wolfram
公开号:US20140135396A1
公开(公告)日:2014-05-15
The invention is directed to the treatment of patients at risk for liver damage due to the overingestion of acetaminophen by administering agents that increase hepatic levels of nitric oxide.